Saltar al contenido
Merck

Transcriptional comparison of human induced and primary midbrain dopaminergic neurons.

Scientific reports (2016-02-05)
Ninuo Xia, Pengbo Zhang, Fang Fang, Zhengyuan Wang, Megan Rothstein, Benjamin Angulo, Rosaria Chiang, James Taylor, Renee A Reijo Pera
RESUMEN

Generation of induced dopaminergic (iDA) neurons may provide a significant step forward towards cell replacement therapy for Parkinson's disease (PD). To study and compare transcriptional programs of induced cells versus primary DA neurons is a preliminary step towards characterizing human iDA neurons. We have optimized a protocol to efficiently generate iDA neurons from human pluripotent stem cells (hPSCs). We then sequenced the transcriptomes of iDA neurons derived from 6 different hPSC lines and compared them to that of primary midbrain (mDA) neurons. We identified a small subset of genes with altered expression in derived iDA neurons from patients with Parkinson's Disease (PD). We also observed that iDA neurons differ significantly from primary mDA neurons in global gene expression, especially in genes related to neuron maturation level. Results suggest iDA neurons from patient iPSCs could be useful for basic and translational studies, including in vitro modeling of PD. However, further refinement of methods of induction and maturation of neurons may better recapitulate full development of mDA neurons from hPSCs.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anticuerpo anti-LMX-1, serum, from rabbit
Sigma-Aldrich
Anti-FOXA2 Antibody, Chemicon®, from rabbit